|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.625 USD | +1.83% |
|
-4.09% | +7.86% |
| 07-14 | Ironwood Pharmaceuticals, Inc. Announces Management Changes | CI |
| 05-27 | Ironwood Says US FDA Approves Linzess Use in Children Aged Two Years and Older With Functional Constipation | MT |
| Market Cap | 586M 509M 473M 436M 821M 55.95B 836M 5.6B 2.19B 27.79B 2.2B 2.15B 93.44B | P/E 2026 * |
3x | P/E 2027 * | 2.88x |
|---|---|---|---|---|---|
| Enterprise Value | 586M 509M 473M 436M 821M 55.95B 836M 5.6B 2.19B 27.79B 2.2B 2.15B 93.44B | EV / Sales 2026 * |
1.27x | EV / Sales 2027 * | 1.23x |
| Free-Float |
96.84% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Ironwood Pharmaceuticals, Inc.
| 1 day | +1.83% | ||
| 1 week | -4.09% | ||
| Current month | -13.66% | ||
| 1 month | -13.66% | ||
| 3 months | -11.88% | ||
| 6 months | -25.66% | ||
| Current year | +7.86% |
| 1 week | 3.55 |  | 3.99 |
| 1 month | 3.55 | | 4.88 |
| Current year | 2.95 | | 5.78 |
| 1 year | 0.72 | | 5.78 |
| 3 years | 0.53 | | 15.7 |
| 5 years | 0.53 | | 15.7 |
| 10 years | 0.53 | | 21.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas McCourt
CEO | Chief Executive Officer | 68 | 11/03/2021 |
Ronald Silver
DFI | Director of Finance/CFO | 44 | 14/05/2026 |
Jeffrey Silber
CTO | Chief Tech/Sci/R&D Officer | - | 19/07/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas McCourt
BRD | Director/Board Member | 68 | 03/06/2021 |
Julie McHugh
CHM | Chairman | 61 | 31/03/2019 |
Marla Kessler
BRD | Director/Board Member | 56 | 31/03/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20/07/26 | Free | Chief Technology Officer | 137,036 | 0.0832% | ||
| 07/07/26 | Sell | Chief Financial Officer | -127,890 | 0.0777% | ||
| 23/02/26 | Sell | Chief Executive Officer | 198,283 | 0.1219% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.83% | -4.09% | +336.32% | -67.22% | 586M | |
| -1.04% | -1.19% | +57.71% | +20.89% | 322B | |
| -1.55% | +2.59% | +28.35% | -10.61% | 71.8B | |
| -0.74% | +2.07% | +37.33% | +92.06% | 9.88B | |
| -1.96% | +0.88% | +2.59% | -1.56% | 8.64B | |
| +2.65% | +1.04% | -23.09% | -5.02% | 4.08B | |
| +5.26% | +5.41% | -38.54% | +12.12% | 3.61B | |
| -3.86% | -8.12% | -14.18% | -2.26% | 3.61B | |
| -1.63% | -2.73% | +36.77% | +49.56% | 2.7B | |
| -0.68% | +4.21% | -7.83% | -5.33% | 2.24B | |
| Average | -0.20% | +1.01% | +41.54% | +8.26% | 42.91B | |
| Weighted average by Cap. | -1.06% | +4.45% | +48.94% | +16.22% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 460M 400M 371M 342M 645M 43.93B 656M 4.39B 1.72B 21.82B 1.73B 1.69B 73.37B | 478M 415M 386M 356M 670M 45.67B 682M 4.57B 1.79B 22.68B 1.8B 1.76B 76.27B |
| Net income | 182M 158M 146M 135M 254M 17.34B 259M 1.73B 679M 8.61B 682M 667M 28.96B | 210M 182M 169M 156M 294M 20.04B 299M 2B 785M 9.95B 788M 771M 33.46B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/07/26 | US$3.615 | +1.54% | 356,197 |
| 29/07/26 | US$3.560 | -6.32% | 1,252,812 |
| 28/07/26 | US$3.800 | -2.81% | 1,821,245 |
| 27/07/26 | US$3.910 | +5.39% | 1,930,760 |
| 24/07/26 | US$3.710 | -2.11% | 1,109,149 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IRWD Stock
Select your edition
All financial news and data tailored to specific country editions
